page_banner

Products

Lasmiditant CAS: 439239-90-4

Short Description:

Catalog Number: XD93695
Cas: 439239-90-4
Molecular Formula: C19H18F3N3O2
Molecular Weight: 377.36
Availability: In Stock 
Price:  
Prepack:  
Bulk Pack: Request Quote

 


Product Detail

Product Tags

Catalog Number XD93695
Product Name Lasmiditant
CAS 439239-90-4
Molecular Formula C19H18F3N3O2
Molecular Weight 377.36
Storage Details Ambient

 

Product Specification

Appearance White powder
Assay 99% min

 

Lasmiditan is a medication commonly prescribed for the acute treatment of migraines in adults. It belongs to a class of drugs known as selective serotonin receptor agonists, which work by stimulating specific serotonin receptors in the brain to alleviate migraine symptoms.Migraines are a debilitating neurological condition characterized by severe headaches, often accompanied by other symptoms such as nausea, vomiting, and sensitivity to light and sound. Lasmiditan is specifically designed to target the underlying mechanisms of migraines and provide relief during an attack.Lasmiditan is available in tablet form and is taken orally. It is recommended to take the medication as soon as possible after the onset of migraine symptoms, although it can also be taken during the migraine attack. The typical starting dose is 50 mg, and a second dose may be taken if needed after at least 2 hours. It is important to follow the prescribed dosage and timing instructions provided by a healthcare professional.The exact mechanism of action of Lasmiditan in relieving migraines is not fully understood. However, it is believed to selectively activate specific serotonin receptors, particularly the 5-HT1F receptor subtype. By targeting these receptors, Lasmiditan inhibits the release of neuropeptides associated with migraines, reduces inflammation, and constricts blood vessels in the brain. This helps to alleviate the intense pain and other symptoms experienced during a migraine attack.Clinical trials have demonstrated the efficacy of Lasmiditan in providing significant relief from migraine symptoms within two hours of administration. It has been shown to be more effective than a placebo in treating migraines. However, it is important to note that Lasmiditan is not intended for the prevention of migraines or for use in chronic daily headache management.Lasmiditan is generally well-tolerated, with the most common side effects including dizziness, fatigue, and sedation. Additionally, it is important to discuss with a healthcare professional before starting Lasmiditan, as it may interact with other medications or have contraindications in certain individuals.In conclusion, Lasmiditan is a widely used medication for the acute treatment of migraines in adults. By selectively activating serotonin receptors in the brain, it provides relief from the intense pain and other symptoms associated with migraines. If prescribed by a healthcare professional and taken as directed, Lasmiditan can be an effective option for individuals seeking relief during a migraine attack.


  • Previous:
  • Next:

  • Close

    Lasmiditant CAS: 439239-90-4